Organisation paid for research Program year 2025 Source: CMS Open Payments

Kannarr Eye Care

Neither a doctor nor a teaching hospital

Research payments

$540,335

71 payments

Through program year 2025, Kannarr Eye Care is reported as receiving $540,335 in research payments, across 71 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$149,397	13
2024	Research	$21,006	7
2023	Research	$35,996	11
2022	Research	$54,164	8
2021	Research	$114,134	12
2020	Research	$7,306	2
2019	Research	$158,331	18

Breakdown

Who paid Research payments · program years 2019–2025

Novartis Pharmaceuticals Corporation $130,622 5 payments
Johnson & Johnson Vision Care, Inc. $121,630 21 payments
Oyster Point Pharma, Inc. $117,345 13 payments
AbbVie, Inc. $62,980 12 payments
Topcon Medical Systems, Inc. $45,000 2 payments
Osmotica Pharmaceutical Corp. $28,070 4 payments
Sun Pharmaceutical Industries Inc. $17,330 10 payments
Shire North American Group Inc $9,245 2 payments
Allergan Inc. $4,779 1 payment
Takeda Pharmaceuticals U.S.A., Inc. $3,334 1 payment

Studies the money was for Research payments · program years 2019–2025

A Randomized, Double-Masked, Vehicle-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment (MR-139), in Subjects With Blepharitis $117,345 13 payments
A Randomized, Placebo-Controlled, Double-Masked, Multi-Center, Dose-Ranging Study to Evaluate the Safety, and Efficacy of Unr844 in Subjects With Presbyopia $85,946 3 payments
Utilization of Topcon Equipment and Interation to Improve Medical Kpi and Office Efficiency $45,000 2 payments
A Randomized, Double-Masked, Multicenter Study to Evaluate the Safety and Efficacy of Ecf843 VS Vehicle in Subjects With Dry Eye Disease $44,676 2 payments
Clinical Evaluation of Triumph Sphere Plano Prototype Contact Lenses I $43,135 3 payments
Short Term Dispensing Evaluation of Comfort and Rotational Performance of Prototype Toric Contact Le $42,839 2 payments
Study of AGN-241622 in Healthy Participants and Participants With Presbyopia $30,485 3 payments
Rvl-202 $22,039 2 payments
Evaluation of comfort, vision and handling of prototype elliptical toric contact lenses $21,115 3 payments
Effect of Cequa in Subjects With Dry Eye Disease $17,330 10 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.